Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Recruiting
N/A
Interventional Study
Spinal Muscular Atrophy (SMA)
Charcot-Marie-Tooth
Muscular Dystrophy
Myotonic Dystrophy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 30 (estimated)
- Sponsor
- Institut de Myologie, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease. Current gait tests only consider the time factor and not the evolution of the patient's biomechanics, which may prove insuff…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* All volunteers
* Age between 18 and 65
* Ambulatory
* Informed consent to participate in the study
* Member of or beneficiary of a social security system
* Volunteers with a neuromuscular disease
* Confirmed diagnosis of a neuromuscular disease of genetic origin (medical document to be…
Contacts